Red White & Bloom Brands (XCNQ:RWB) Days Payable: 76.12 (As of Mar. 2026) — 32% Below Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Red White & Bloom Brands Days Payable?

Red White & Bloom Brands XCNQ:RWB Days Payable is 76.12 as of Mar. 2026, which is 32% below its 10-year median of 111.80. The stock has 7 warning signs investors should review. Among 925 Drug Manufacturers companies, Red White & Bloom Brands ranks worse than 50.49% on this metric.

Red White & Bloom Brands's average Accounts Payable for the three months ended in Mar. 2026 was C$8.43 Mil. Red White & Bloom Brands's Cost of Goods Sold for the three months ended in Mar. 2026 was C$10.10 Mil. Hence, Red White & Bloom Brands's Days Payable for the three months ended in Mar. 2026 was 76.12.

The historical rank and industry rank for Red White & Bloom Brands's Days Payable or its related term are showing as below:

XCNQ:RWB' s Days Payable Range Over the Past 10 Years
Min: 82.38   Med: 111.8   Max: 729.48
Current: 88.45

During the past 7 years, Red White & Bloom Brands's highest Days Payable was 729.48. The lowest was 82.38. And the median was 111.80.

XCNQ:RWB's Days Payable is ranked worse than
50.49% of 925 companies
in the Drug Manufacturers industry
Industry Median: 88.85 vs XCNQ:RWB: 88.45

Red White & Bloom Brands's Days Payable declined from Mar. 2025 (79.47) to Mar. 2026 (76.12). It may suggest that Red White & Bloom Brands accelerated paying its suppliers.


Red White & Bloom Brands Days Payable Historical Data

* Premium members only.

The historical data trend for Red White & Bloom Brands's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Red White & Bloom Brands Days Payable Chart

Red White & Bloom Brands Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Days Payable
Get a 7-Day Free Trial 463.85 82.38 125.87 97.73 95.11

Red White & Bloom Brands Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Days Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 79.47 69.52 95.12 124.47 76.12

XCNQ:RWB vs ZTS: Days Payable Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Red White & Bloom Brands's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Red White & Bloom Brands Days Payable vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Red White & Bloom Brands's Days Payable distribution charts can be found below:

* The bar in red indicates where Red White & Bloom Brands's Days Payable falls into.



Red White & Bloom Brands Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Red White & Bloom Brands's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as

Days Payable (A: Dec. 2025 )
=Average Accounts Payable /Cost of Goods Sold*Days in Period
=( (Accounts Payable (A: Dec. 2024 ) + Accounts Payable (A: Dec. 2025 )) / count ) / Cost of Goods Sold (A: Dec. 2025 )*Days in Period
=( (14.761 + 7.257) / 2 ) / 42.251*365
=11.009 / 42.251*365
=95.11

Red White & Bloom Brands's Days Payable for the quarter that ended in Mar. 2026 is calculated as:

Days Payable (Q: Mar. 2026 )
=Average Accounts Payable / Cost of Goods Sold*Days in Period
=( (Accounts Payable (Q: Dec. 2025 ) + Accounts Payable (Q: Mar. 2026 )) / count ) / Cost of Goods Sold (Q: Mar. 2026 )*Days in Period
=( (7.257 + 9.598) / 2 ) / 10.102*365 / 4
=8.4275 / 10.102*365 / 4
=76.12

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Days Payable →
What does a Days Payable of 76.12 mean?
Red White & Bloom Brands (XCNQ:RWB) has a Days Payable of 76.12 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Red White & Bloom Brands and its competitors. This is 32% below median its historical median of 111.80. Over the past decade, Red White & Bloom Brands' Days Payable has ranged from 82.38 to 729.48. According to the industry distribution chart, Red White & Bloom Brands ranks #467 out of 925 companies in the Drug Manufacturers industry, placing it in the top 50.5%.
Is Red White & Bloom Brands' Days Payable too high?
Red White & Bloom Brands' current Days Payable of 76.12 is 32% below median its 10-year median of 111.80. Over the past 10 years, this metric has ranged from a low of 82.38 to a high of 729.48. The Drug Manufacturers industry median Days Payable is 88.85. Red White & Bloom Brands' value of 76.12 is 14.3% below this industry median. Based on the distribution chart, Red White & Bloom Brands ranks #467 out of 925 companies in the Drug Manufacturers industry, which is below the industry midpoint.
How does Red White & Bloom Brands' Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Red White & Bloom Brands ranks #467 out of 925 companies for Days Payable. This places Red White & Bloom Brands in the lower half of its industry. The industry median Days Payable is 88.85. Red White & Bloom Brands' value of 76.12 is 14.3% below this benchmark. Historically, Red White & Bloom Brands' own Days Payable has ranged from 82.38 to 729.48 over the past decade. While the company's 10-year median is 111.80 vs. the industry median of 88.85, Red White & Bloom Brands has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.85, based on 925 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Red White & Bloom Brands's current Days Payable of 76.12 is 14.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Red White & Bloom Brands and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.85 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Red White & Bloom Brands's current Days Payable is 76.12, which is 32% below median its own 10-year median of 111.80. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Red White & Bloom Brands stock overvalued right now?
Based on GuruFocus' analysis, Red White & Bloom Brands (XCNQ:RWB) is currently considered Modestly Undervalued. The stock's GF Value™ is C$0.04, compared to a current price of C$0.03 — trading 25% below its estimated fair value. The current Days Payable is 76.12, which is 32% below median its 10-year median of 111.80 and 14.3% below the Drug Manufacturers industry median of 88.85. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Red White & Bloom Brands (XCNQ:RWB), the current Days Payable is 76.12 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Red White & Bloom Brands Business Description

Address 1890-1075 West Georgia Street, Vancouver, BC, CAN, V6E 3C9
Red White & Bloom Brands Inc is a multi-state operator in the United States conducting operations in the legal cannabis industry. The principal activity of the company is the sale of a diverse range of high-quality cannabis-based products delivered through its distribution and retail channels. The company operates twelve licensed adult-use and medical retail dispensaries located in the legal states of Michigan and Florida. The company operates in reportable segments: Corporate segment, Distribution segment, Licensing segment, Retail segment and Other. The key revenue is generated from Distribution segment. Geographically, the company operates in USA and Canada, where majority revenue is generated from USA.